Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Y Lu

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Delivering small interfering RNA for novel therapeuticsPatrick Y Lu, Martin C Woodle
Advances in Genetics|August 13, 2005
In vivo application of RNA interference: from functional genomics to therapeuticsPatrick Y Lu, Frank Xie, Martin C Woodle
Trends in Molecular Medicine|March 12, 2005
Modulation of angiogenesis with siRNA inhibitors for novel therapeuticsPatrick Y Lu, Frank Y Xie, Martin C Woodle
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Application of siRNA against SARS in the rhesus macaque modelQingquan Tang, Baojian Li, Martin Woodle, et al.
Drug Discovery Today|February 16, 2006
Harnessing in vivo siRNA delivery for drug discovery and therapeutic developmentFrank Y Xie, Martin C Woodle, Patrick Y Lu
Current Opinion in Molecular Therapeutics|July 23, 2003
siRNA-mediated antitumorigenesis for drug target validation and therapeuticsPatrick Y Lu, Frank Y Xie, Martin C Woodle
Drugs of the Future|February 18, 2010
Advances in Systemic siRNA DeliveryQixin Leng, Martin C Woodle, Patrick Y Lu, et al.
Molecular Therapy. Nucleic Acids|August 6, 2014
Oligonucleotide aptamers: new tools for targeted cancer therapyHongguang Sun, Xun Zhu, Patrick Y Lu, et al.
Future Medicinal Chemistry|March 24, 2011
Leveraging therapeutic potential of multi-targeted siRNA inhibitorsQing Ge, John J Xu, David M Evans, et al.
Molecular Cancer Therapeutics|June 6, 2008
Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growthZhenwen Yan, Huafei Zou, Fang Tian, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Delivering small interfering RNA for novel therapeuticsPatrick Y Lu, Martin C Woodle
Advances in Genetics|August 13, 2005
In vivo application of RNA interference: from functional genomics to therapeuticsPatrick Y Lu, Frank Xie, Martin C Woodle
Trends in Molecular Medicine|March 12, 2005
Modulation of angiogenesis with siRNA inhibitors for novel therapeuticsPatrick Y Lu, Frank Y Xie, Martin C Woodle
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Application of siRNA against SARS in the rhesus macaque modelQingquan Tang, Baojian Li, Martin Woodle, et al.
Drug Discovery Today|February 16, 2006
Harnessing in vivo siRNA delivery for drug discovery and therapeutic developmentFrank Y Xie, Martin C Woodle, Patrick Y Lu
Current Opinion in Molecular Therapeutics|July 23, 2003
siRNA-mediated antitumorigenesis for drug target validation and therapeuticsPatrick Y Lu, Frank Y Xie, Martin C Woodle
Drugs of the Future|February 18, 2010
Advances in Systemic siRNA DeliveryQixin Leng, Martin C Woodle, Patrick Y Lu, et al.
Molecular Therapy. Nucleic Acids|August 6, 2014
Oligonucleotide aptamers: new tools for targeted cancer therapyHongguang Sun, Xun Zhu, Patrick Y Lu, et al.
Future Medicinal Chemistry|March 24, 2011
Leveraging therapeutic potential of multi-targeted siRNA inhibitorsQing Ge, John J Xu, David M Evans, et al.
Molecular Cancer Therapeutics|June 6, 2008
Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growthZhenwen Yan, Huafei Zou, Fang Tian, et al.
Pageof 2